Read More 1 minute read Analyst Ratings News Price Target Reiteration Credit Suisse Reiterates Outperform on AbCellera Biologics, Maintains $34 Price Target By Benzinga Newsdesk February 22, 8:33 AM Credit Suisse analyst Tiago Fauth reiterates AbCellera Biologics (NASDAQ:ABCL) with a Outperform and maintains $34 price target. ABCL
Read More 1 minute read Analyst Ratings News Price Target Reiteration Credit Suisse Reiterates Neutral on TPG, Maintains $36 Price Target By Benzinga Newsdesk February 22, 8:27 AM Credit Suisse analyst Bill Katz reiterates TPG (NASDAQ:TPG) with a Neutral and maintains $36 price target. TPG
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Adtran, Maintains $28 Price Target By Benzinga Newsdesk February 22, 8:20 AM Needham analyst Ryan Koontz reiterates Adtran (NASDAQ:ADTN) with a Buy and maintains $28 price target. ADTN
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target By Benzinga Newsdesk February 22, 8:16 AM HC Wainwright & Co. analyst Joseph Pantginis reiterates Pharming (NASDAQ:PHAR) with a Buy and maintains $37 price target. PHAR
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Belite Bio, Maintains $58 Price Target By Benzinga Newsdesk February 22, 8:14 AM HC Wainwright & Co. analyst Yi Chen reiterates Belite Bio (NASDAQ:BLTE) with a Buy and maintains $58 price target. BLTE
Read More 1 minute read Analyst Color Analyst Ratings Cryptocurrency Fintech Markets News Previews Price Target Reiteration Tech Trading Ideas Block Analyst Ups Price Target For Stock Ahead Of Q4 Results: ‘We Are Positive, Headed Into The Print…’ By Shanthi Rexaline February 22, 7:34 AM Jack Dorsey-led Block Inc. (NYSE: SQ) is scheduled to release its fourth-quarter results on Thursday after the market close. BTC
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Asensus Surgical, Maintains $3 Price Target By Benzinga Newsdesk February 22, 7:10 AM HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Asensus Surgical (AMEX:ASXC) with a Buy and maintains $3 price target. ASXC
Read More 1 minute read Analyst Ratings News Price Target Reiteration Cowen & Co. Reiterates Market Perform on Jack In The Box, Maintains $80 Price Target By Benzinga Newsdesk February 22, 6:44 AM Cowen & Co. analyst Andrew Charles reiterates Jack In The Box (NASDAQ:JACK) with a Market Perform and maintains $80 price target. JACK
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on AtriCure, Maintains $58 Price Target By Benzinga Newsdesk February 22, 6:42 AM Needham analyst Mike Matson reiterates AtriCure (NASDAQ:ATRC) with a Buy and maintains $58 price target. ATRC
Read More 1 minute read Analyst Ratings News Price Target Reiteration Telsey Advisory Group Reiterates Market Perform on American Eagle Outfitters, Maintains $17 Price Target By Benzinga Newsdesk February 22, 6:06 AM Telsey Advisory Group analyst Dana Telsey reiterates American Eagle Outfitters (NYSE:AEO) with a Market Perform and maintains $17 price target. AEO